Neoplasia


26


Neoplasia


Chapter map


Malignant disease is the second most common cause of death in childhood after accidents. Leukaemia has the highest incidence (Figure 26.1). With 1200 newly diagnosed UK cases a year, a child has a 1 in 600 chance of developing a malignancy before reaching adulthood. There has been steady improvement in outcome over the past decades due to ongoing treatment development, and the fact that most patients are entered into multicentre clinical trials. For the 0-14 year age-group, 5-year survival is 80% in Europe and the USA. Cure rates vary by tumour type, from around 60% for acute myeloid leukaemia, neuroblastoma and CNS tumours, to above 90% for Hodgkin’s lymphoma.


26.1 Acute leukaemia


26.2 Lymphomas


26.3 Central nervous system tumours


26.4 Neuroblastoma


26.5 Wilms tumour (nephroblastoma)


26.6 Bone tumours


26.7 Treatment of childhood malignancy


Summary


Reference



Figure 26.1 Incidence of childhood malignancy in Europe. New cases per million population. Source: adapted from data in Kaatsch (2010).

c26f001






Most common malignancies


  • Leukaemia
  • Lymphoma
  • CNS tumours.





The relative frequency of different types of malignancy varies through childhood (Figure 26.2). In contrast to adult disease, childhood epithelial malignancies (e.g. carcinoma of the lung and gastrointestinal tract) are very rare. In children, the prognosis for malignancy is better than in adults (Table 26.1). Some genetic conditions increase the lifetime risk of cancer (e.g. Down syndrome, neurofibromatosis).



Figure 26.2 Relative incidence of malignancies through childhood.

c26f002

Table 26.1 5-year survival rates (%) for childhood malignancy































5 year survival
Malignancy rate (%)
Hodgkin’s lymphoma 95
Wilm’s tumour 84
Astrocytoma 83
Acute lymphoblastic leukaemia 84
Osteosarcoma 68
Neuroblastoma 73
All childhood malignancy 80

Early diagnosis improves outcomes. However, many of the initial presenting signs and symptoms are relatively common in the general population, so care is needed, and a high index of suspicion (Table 26.2). Early review, further investigation, or urgent referral should be considered.


Table 26.2 Common symptoms – when to worry






















Malignancy unlikely* Malignancy more likely
Lymphadenopathy Smooth, mobile, <2 cm
Cervical or small inguinal
Well child
Hard, craggy, tethered
Bruising, pallor, fever
Hepatosplenomegaly
Headaches Typical migraine or stress headache
Longstanding in older child
No neurological signs or symptoms
No other concerning symptoms (see section on central nervous system tumours below)
Present on waking
Worse on coughing/sneezing
Recent onset, worsening or persistent
Any neurological signs/symptoms
Any other concerning symptoms
Aches and pains Vague, difficult to localize
Well child
No local signs
Localized pain
Local signs (e.g. swelling and tenderness)
Unusual pain (e.g. back pain in a toddler)
*Note that there may be other differential diagnoses for these symptoms.

26.1 Acute leukaemia


Leukaemia is characterized by the malignant proliferation of abnormal white cells (blasts) within the bone marrow. Acute lymphoblastic leukaemia accounts for 85% of cases. It is more common in boys and has a peak incidence between 2 and 5 years of age.





Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 7, 2016 | Posted by in PEDIATRICS | Comments Off on Neoplasia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access